The story
The 2018 health law promised medical cannabis under conditions the minister would set; the order of 27 February 2021 set them. Growing and producing narcotics for medical and scientific purposes needed a five-year authorisation, reserved to Congolese organisations operating at industrial scale.[1]
The order drew a hard line around the plant: medical varieties had to contain no more than 0.2% THC with high CBD content, and every non-medical purpose stayed prohibited.[1] The shape proved durable — the revised order of 24 November 2022 kept the industrial-scale authorisations, the THC ceiling and the ban on prescribing or dispensing narcotics in kind.[2]
What the orders built was a licensed production framework with no patients at the end of it. Authorisations run to exclusively industrial organisations, imports and exports of semi-finished and finished products need authorisation while raw cannabis exports are prohibited, and no operating patient supply was verified.[2]
Listed for context. No score change is recorded for DR Congo here.
References
Checked. The date and the event were compared with a source that was read.